Jian'an Wang, Xianbao Liu, Zhaoxia Pu, Mao Chen, Zhenfei Fang, Jun Jin, Jianzhen Dong, Yansong Guo, Biao Cheng, Jiancheng Xiu, Jianfang Luo, Yida Tang, Yan Wang, Xiaomen Chen, Gejun Zhang, Yibing Shao, Guangyuan Song, Lang Hong, Hong Jiang, Yangqin Wu, Yiqiang Yuan, Lianglong Chen, Ben He, Jingfeng Wang, Kai Xu, Yining Yang, Daxin Zhou, Qi Zhang, Yi Li, Kangmu Ma, Yat-Yin Lam, Yaling Han, Junbo Ge, D Scott Lim, For The Dragonflydmr Pivotal Trial Investigators
BACKGROUND: Severe degenerative mitral regurgitation (DMR) can cause a poor prognosis if left untreated. For patients considered at prohibitive surgical risk, transcatheter edge-to-edge repair (TEER) has become an accepted alternative therapy. The DragonFly transcatheter valve repair system is an innovative evolution of the mitral TEER device family to treat DMR. AIMS: Herein we report on the DRAGONFLY-DMR trial (ClinicalTrials.gov: NCT04734756), which was a prospective, single-arm, multicentre study on the safety and effectiveness of the DragonFly system...
February 19, 2024: EuroIntervention